TCT 2019: Evolve Short DAPT And Model U-SUS Study Show Short DAPT Was Comparable To Longer-Term DAPT
Data from two studies that looked at the safety of three-months dual antiplatelet therapy versus longer-term DAPT therapy, presented on 26 September at the Transcatheter Cardiovascular Therapeutics conference in San Francisco, showed non-inferiority for short-term DAPT.
Short-term versus long-term safety of dual antiplatelet therapy (DAPT) with drug-eluting stents is dominating much of the conversation at the Transcatheter Cardiovascular Therapeutics (TCT) meeting in San Francisco.
Results of two separate studies, EVOLVE Short DAPT and Model U-SES, that looked at the safety of three-month...
